Research
Hormonal
GLP-1 RA therapy improved HBA1C levels from 6.4 to 5.7 (p-value 0.003) in LVAD patients.
GLP-1 RA may help improve glycemic control in LVAD patients.
StrongSupportsmedium confidence
HBA1C was improved (6.4 (5.8-8.1) vs. 5.7 (5.3-6.1), p-value 0.003).
Why this rating
Based on a retrospective analysis of patient outcomes.
Source
Glucagon‐Like Peptide‐1 Receptor Agonists in Patients With Durable Left Ventricular Assist Devices
B. Elad et al. · Artificial Organs · 2025
cohort · n=40Cited 4×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →